Management of Anticoagulation and Antiplatelet Therapy in Patients With Primary Membranous Nephropathy

BMC Nephrology - United Kingdom
doi 10.1186/s12882-019-1637-y
Full Text
Abstract

Available in full text

Categories
Nephrology
Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Personalized Antiplatelet and Anticoagulation Therapy: Pharmacogenomics

Japanese Journal of Thrombosis and Hemostasis
2019English

Anticoagulation and Antiplatelet Therapy, and Gastrointestinal Endoscopy

Orvosi Hetilap
Medicine
2009English

Management of Membranous Nephropathy After MENTOR

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2019English

Clinicopathological Features and Prognosis in Patients With Idiopathic Membranous Nephropathy With Hypertension

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2020English

Membranous Nephropathy

2019English

Primary Membranous Nephropathy as a Model of Autoimmune Disease

2019English

Management of Idiopathic Membranous Nephropathy: Evidence-Based Recommendations

Kidney International
Nephrology
1999English

PLA2R Antibodies and PLA2R Glomerular Deposits in Psoriasis Patients With Membranous Nephropathy

BMC Nephrology
Nephrology
2016English

Variation of Peripheral Th17/Treg Imbalance in Patients With Idiopathic Membranous Nephropathy After Cyclosporin a Treatment: A Prognostic Marker of Idiopathic Membranous Nephropathy

Biomedical Journal of Scientific & Technical Research
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy